Patents by Inventor Brian Laster

Brian Laster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10624845
    Abstract: An oral dosage form to deliver diphenhydramine through the sublingual or buccal mucosa. The oral dosage form can contain diphenhydramine, or a pharmaceutically acceptable salt thereof, a permeability enhancer, and a buffering agent. The buffering agent can achieve a pH of about 7.0 to about 8.0. The diphenhydramine can completely dissolve within about 2 minutes.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: April 21, 2020
    Assignee: The Procter & Gamble Company
    Inventors: Richard John Dansereau, Brian Laster, Erin Swigart, Ashraf Traboulsi
  • Publication number: 20190015321
    Abstract: An oral dosage form to deliver diphenhydramine through the sublingual or buccal mucosa. The oral dosage form can contain diphenhydramine, or a pharmaceutically acceptable salt thereof, a permeability enhancer, and a buffering agent. The buffering agent can achieve a pH of about 7.0 to about 8.0. The diphenhydramine can completely dissolve within about 2 minutes.
    Type: Application
    Filed: August 30, 2018
    Publication date: January 17, 2019
    Inventors: Richard John Dansereau, Brian Laster, Erin Swigart, Ashraf Traboulsi
  • Patent number: 10085954
    Abstract: An oral dosage form to deliver diphenhydramine through the sublingual or buccal mucosa. The oral dosage form can contain diphenhydramine, or a pharmaceutically acceptable salt thereof, a permeability enhancer, and a buffering agent. The buffering agent can achieve a pH of about 7.0 to about 8.0. The diphenhydramine can completely dissolve within about 2 minutes.
    Type: Grant
    Filed: November 28, 2017
    Date of Patent: October 2, 2018
    Assignee: The Procter & Gamble Company
    Inventors: Richard John Dansereau, Brian Laster, Erin Swigart, Ashraf Traboulsi
  • Publication number: 20180078514
    Abstract: An oral dosage form to deliver diphenhydramine through the sublingual or buccal mucosa. The oral dosage form can contain diphenhydramine, or a pharmaceutically acceptable salt thereof, a permeability enhancer, and a buffering agent. The buffering agent can achieve a pH of about 7.0 to about 8.0. The diphenhydramine can completely dissolve within about 2 minutes.
    Type: Application
    Filed: November 28, 2017
    Publication date: March 22, 2018
    Inventors: Richard John Dansereau, Brian Laster, Erin Swigart, Ashraf Traboulsi
  • Patent number: 9855227
    Abstract: An oral dosage form to deliver diphenhydramine through the sublingual or buccal mucosa. The oral dosage form can contain diphenhydramine, or a pharmaceutically acceptable salt thereof, a permeability enhancer, and a buffering agent. The buffering agent can achieve a pH of about 7.0 to about 8.0. The diphenhydramine can completely dissolve within about 2 minutes.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: January 2, 2018
    Assignee: The Procter & Gamble Company
    Inventors: Richard John Dansereau, Brian Laster, Erin Swigart, Ashraf Traboulsi
  • Publication number: 20170172948
    Abstract: An oral dosage form to deliver diphenhydramine through the sublingual or buccal mucosa. The oral dosage form can contain diphenhydramine, or a pharmaceutically acceptable salt thereof, a permeability enhancer, and a buffering agent. The buffering agent can achieve a pH of about 7.0 to about 8.0. The diphenhydramine can completely dissolve within about 2 minutes.
    Type: Application
    Filed: December 18, 2015
    Publication date: June 22, 2017
    Inventors: Richard John Dansereau, Brian Laster, Erin Swigart, Ashraf Traboulsi